U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing ...

Hamster IFN-γ ELISPOT was performed using the ELISpot Flex ... Neutralizing antibodies in the sera were measured at day 28 post-inoculation using the following authentic SARS-CoV-2 strains: wild-type ...

reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global concerns about drug shortages of other therapies, PharmaEssentia ...

To examine the effect apigenin and luteolin had on microglial activation via CD40, we initially treated N9 microglia cells over a range of concentrations. Following FACS analysis, we found that ...

From the Centers of Inflammation, Translational, and Clinical Lung Research (Y. Shao, Y. Sun, Y.L., F.S., C.D., C.J., K.X., X.J., X.Y.), Temple University, Lewis Katz ...

Hubei Key Laboratory of Electrochemical Power Sources, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China Beijing Key Laboratory of Theory and Technology for ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...

Joint School of National University of Singapore and Tianjin University, International Campus of Tianjin University Fuzhou, Fuzhou 350207, China Department of Chemical and Biomolecular Engineering, ...

The investigators concluded that SOCS1 needs to exceed a threshold level to inhibit both IFN-gamma and GM-CSF signaling. Furthermore, “the ability of SOCS1 to cross-regulate GM-CSF signaling is ...

Figure 1 (A) Key characteristics of the two main γδ T-cell subsets, Vδ2 and Vδ1 T-cells, in cancer biology. (B) Schematic representation of therapeutic strategies involving γδ T-cells that are ...